- Home
- EW vs CBRE Comparison
EW vs CBRE Comparison
Compare EW & CBRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EW | CBRE |
|---|---|---|
| Founded | 1958 | 1906 |
| Country | United States | United States |
| Employees | N/A | 44000 |
| Industry | Industrial Specialties | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2B | 41.5B |
| IPO Year | 1999 | 2001 |
Fundamental Metrics
Financial Performance| Metric | EW | CBRE |
|---|---|---|
| Price | $82.49 | $130.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 7 |
| Target Price | $96.37 | ★ $177.86 |
| AVG Volume (30 Days) | ★ 4.9M | 2.0M |
| Earning Date | 04-23-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.61 |
| EPS | 0.66 | ★ 1.07 |
| Revenue | $6,067,600,000.00 | ★ $40,550,000,000.00 |
| Revenue This Year | $13.39 | $14.31 |
| Revenue Next Year | $9.81 | $9.06 |
| P/E Ratio | $123.42 | ★ $121.81 |
| Revenue Growth | 11.55 | ★ 13.37 |
| 52 Week Low | $72.30 | $118.81 |
| 52 Week High | $87.89 | $174.27 |
Technical Indicators
Market Signals| Indicator | EW | CBRE |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 30.07 |
| Support Level | $81.39 | $127.40 |
| Resistance Level | $82.56 | $138.73 |
| Average True Range (ATR) | 2.47 | 4.52 |
| MACD | -0.02 | -1.90 |
| Stochastic Oscillator | 68.24 | 16.34 |
Price Performance
Historical ComparisonAbout EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
About CBRE CBRE Group Inc
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm managed over $155 billion (at year-end 2025) for clients across diverse public and private real estate strategies.